Fernwood Investment Management’s Cytokinetics CYTK Stock Holding History

Fernwood Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$470K	Hold	10,000	–	–	0.16%	110
2024 Q3	$528K	Hold	10,000	–	–	0.17%	117
2024 Q2	$542K	Hold	10,000	–	–	0.17%	117
2024 Q1	$701K	Hold	10,000	–	–	0.2%	96
2023 Q4	$835K	Hold	10,000	–	–	0.28%	83
2023 Q3	$295K	Hold	10,000	–	–	0.11%	149
2023 Q2	$326K	Hold	10,000	–	–	0.12%	144
2023 Q1	$352K	Hold	10,000	–	–	0.14%	143
2022 Q4	$458K	Hold	10,000	–	–	0.19%	120
2022 Q3	$484K	Hold	10,000	–	–	0.2%	114
2022 Q2	$393K	Hold	10,000	–	–	0.17%	129
2022 Q1	$368K	Hold	10,000	–	–	0.13%	145
2021 Q4	$456K	Hold	10,000	–	–	0.15%	139
2021 Q3	$357K	Buy	+10,000	New	+$294K	0.12%	148

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fernwood Investment Management's CYTK Position: Q4 2024 in Review

Fernwood Investment Management held its Cytokinetics (CYTK) position steady in Q4 2024 at 10,000 shares worth $470K. The position accounts for 0.16% of the portfolio, ranked #110.

Fernwood Investment Management first reported a position in CYTK in Q3 2021 and has held it in 14 quarters since. The position peaked at $835K in Q4 2023. 346 funds tracked by Wall St. Rank hold CYTK as of Q4 2024.

Fernwood Investment Management held 10,000 shares of Cytokinetics worth $470K as of Q4 2024.
Fernwood Investment Management left its Cytokinetics share count unchanged in Q4 2024.
Cytokinetics made up 0.16% of Fernwood Investment Management's portfolio in Q4 2024, its #110 holding.
Fernwood Investment Management first reported a position in Cytokinetics in Q3 2021 and has held it in 14 quarters since.
Fernwood Investment Management's Cytokinetics position peaked at $835K in Q4 2023.
346 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.